Unique precision medicine with a dual targeting of CD8+ CXCR3+ T cells offers potential for a first-in-class targeted systemic ... Unique potential as a first-in-class, oral, targeted systemic therapy ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. The gut microbiome, or the community of ...

Presentation to take place on January 15, 2025, at 15:00 PST / 00:00 CET and will be available for replay on demand Idorsia Ltd (SIX: IDIA) today announced that André C. Muller, Chief Executive ...

Ki-67 staining, a scratch experiment, real-time PCR, and Western blotting were used to explore the effect of the Th17 cell supernatant on keloid fibroblasts. Results: Our findings revealed the ...

M1 macrophages produce pro-inflammatory mediators like nitric oxide, TNFα, IL-23, IL-12, and IL-1β, whereby they kill pathogens and promote the polarization of T helper (Th) cells to T helper 1 (Th1) ...

Adaptive Immunity Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano, Italy (E.M., M.C., E.P., V.P., C.C., F ...